PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8719627-5	1995	Initially, the effect on capillary permeability of increasing doses of TNF, using [14C]sucrose uptake, was measured.	Carbon-14	83-86	tumor necrosis factor	Rattus norvegicus	71-74	
8641197-3	1996	The effect of TNF-alpha was more pronounced when the incubation period was extended to 6 and 12 h. TNF-alpha also blocked insulin activation of glycogen synthase (GS) and inhibited glycogen synthesis (measured as [14C]-glucose incorporated into glycogen).	Carbon-14	214-218	tumor necrosis factor	Rattus norvegicus	14-23	
8641197-3	1996	The effect of TNF-alpha was more pronounced when the incubation period was extended to 6 and 12 h. TNF-alpha also blocked insulin activation of glycogen synthase (GS) and inhibited glycogen synthesis (measured as [14C]-glucose incorporated into glycogen).	Carbon-14	214-218	tumor necrosis factor	Rattus norvegicus	99-108	
8549863-6	1996	Used alone or in combination, TNF and IFN significantly enhanced the activity of inducible nitric oxide synthase as determined by measuring the conversion of 14C-labeled arginine to 14C-labeled citrulline and nitric oxide.	Carbon-14	158-161	tumor necrosis factor	Rattus norvegicus	30-33	
8549863-6	1996	Used alone or in combination, TNF and IFN significantly enhanced the activity of inducible nitric oxide synthase as determined by measuring the conversion of 14C-labeled arginine to 14C-labeled citrulline and nitric oxide.	Carbon-14	182-185	tumor necrosis factor	Rattus norvegicus	30-33	
15713255-6	2005	Studies directly measuring [14C]-glutamate uptake in HEC slices indicate that TNF alpha dose-dependently inhibited glutamate uptake.	Carbon-14	28-31	tumor necrosis factor	Rattus norvegicus	78-87	
1513334-4	1992	In addition, [14C]lipid accumulation from [U-14C]glucose was increased both in liver and brown adipose tissue of the TNF-injected animals.	Carbon-14	14-17	tumor necrosis factor	Rattus norvegicus	117-120	
1689552-2	1990	We studied the effect of human recombinant TNF alpha (rTNF alpha) on transfer of 14C-labeled bovine serum albumin (BSA) across cultured bovine pulmonary arterial endothelial cell monolayers.	Carbon-14	81-84	tumor necrosis factor	Rattus norvegicus	54-64	
2917156-6	1989	Disappearance of 14C-labeled triacylglycerol from the circulation after injection of small chylomicrons, biosynthetically labeled in their triacylglycerol and cholesterol moieties, was lower in TNF-treated than in control rats.	Carbon-14	17-20	tumor necrosis factor	Rattus norvegicus	194-197	
7628396-1	1995	The administration of an acute tumor necrosis factor-alpha (TNF) dose (100 micrograms/kg BW) to 20-day pregnant rats resulted in a substantial decrease in the fetal availability of maternally administered amino acids, as measured by the accumulation of alpha-amino-[1-14C]isobutyrate ([14C]AIB) and [1-14C]cycloleucine ([14C]CLEU), nonmetabolizable analogs of the amino acids alanine and leucine, respectively.	Carbon-14	268-271	tumor necrosis factor	Rattus norvegicus	31-58	
7628396-1	1995	The administration of an acute tumor necrosis factor-alpha (TNF) dose (100 micrograms/kg BW) to 20-day pregnant rats resulted in a substantial decrease in the fetal availability of maternally administered amino acids, as measured by the accumulation of alpha-amino-[1-14C]isobutyrate ([14C]AIB) and [1-14C]cycloleucine ([14C]CLEU), nonmetabolizable analogs of the amino acids alanine and leucine, respectively.	Carbon-14	268-271	tumor necrosis factor	Rattus norvegicus	60-63	
7628396-1	1995	The administration of an acute tumor necrosis factor-alpha (TNF) dose (100 micrograms/kg BW) to 20-day pregnant rats resulted in a substantial decrease in the fetal availability of maternally administered amino acids, as measured by the accumulation of alpha-amino-[1-14C]isobutyrate ([14C]AIB) and [1-14C]cycloleucine ([14C]CLEU), nonmetabolizable analogs of the amino acids alanine and leucine, respectively.	Carbon-14	286-289	tumor necrosis factor	Rattus norvegicus	31-58	
7628396-1	1995	The administration of an acute tumor necrosis factor-alpha (TNF) dose (100 micrograms/kg BW) to 20-day pregnant rats resulted in a substantial decrease in the fetal availability of maternally administered amino acids, as measured by the accumulation of alpha-amino-[1-14C]isobutyrate ([14C]AIB) and [1-14C]cycloleucine ([14C]CLEU), nonmetabolizable analogs of the amino acids alanine and leucine, respectively.	Carbon-14	286-289	tumor necrosis factor	Rattus norvegicus	60-63	
7628396-4	1995	In skeletal muscle and heart, TNF treatment resulted in decreased [14C]AIB accumulation, but increased [14C]CLEU.	Carbon-14	67-70	tumor necrosis factor	Rattus norvegicus	30-33	
7628396-4	1995	In skeletal muscle and heart, TNF treatment resulted in decreased [14C]AIB accumulation, but increased [14C]CLEU.	Carbon-14	104-107	tumor necrosis factor	Rattus norvegicus	30-33	
3223945-0	1988	Tumour necrosis factor alpha (cachectin) mimics some of the effects of tumour growth on the disposal of a [14C]lipid load in virgin, lactating and litter-removed rats.	Carbon-14	107-110	tumor necrosis factor	Rattus norvegicus	30-39